A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes
Condition(s):Diabetes Mellitus, Type 2Last Updated:November 14, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes Mellitus, Type 2Last Updated:November 14, 2022Completed
Condition(s):MigraineLast Updated:July 29, 2022Completed
Condition(s):Early Parkinson DiseaseLast Updated:November 30, 2023Active, not recruiting
Condition(s):Unresectable Locally Advanced Urothelial Cancer; Metastatic Urothelial CancerLast Updated:February 12, 2024Active, not recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:November 23, 2022Completed
Condition(s):Diabetic Macular EdemaLast Updated:March 7, 2023Completed
Condition(s):Systemic Lupus ErythematosusLast Updated:March 7, 2024Recruiting
Condition(s):Acinetobacter Baumannii-calcoaceticus Complex; Hospital-acquired Bacterial Pneumonia; Ventilator-associated Bacterial Pneumonia; Bacteremia; Colistin Resistant ABCLast Updated:February 1, 2023Completed
Condition(s):Relapsing Multiple SclerosisLast Updated:February 5, 2024Recruiting
Condition(s):Breast Cancer; Breast Neoplasms; HER2-positive Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast CancerLast Updated:January 14, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.